Clinical Correlates of Similar Pathologies in Parkinsonian Syndromes

被引:15
|
作者
Song, Yun Ju Christine
Huang, Yue
Halliday, Glenda Margaret [1 ]
机构
[1] Neurosci Res Australia, Randwick, NSW 2031, Australia
基金
英国医学研究理事会;
关键词
atrophy; clinical features; multiple system atrophy; Parkinson's disease; pathological severity; progressive supranuclear palsy; PROGRESSIVE SUPRANUCLEAR PALSY; MULTIPLE SYSTEM ATROPHY; SUPERIOR CEREBELLAR PEDUNCLE; DOPAMINE TRANSPORTER; DIAGNOSTIC-CRITERIA; DISEASE; MRI; INVOLVEMENT; DISORDERS; SUBTYPES;
D O I
10.1002/mds.23336
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: There have been no previous studies assessing the severity of regional atrophy, cell loss and lesion densities between the overlapping conditions of Parkinson's disease (PD), progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) and relating these pathologies to different clinical features. Methods: Clinical indices and basal ganglia, brainstem, and cerebellar pathology from 43 longitudinally studied cases (PD = 8, PSP = 15, MSA = 12, controls = 8) were compared. A point-counting method was used to evaluate subregional volumes, and a-synuclein and phospho-tau immunohistochemistry was used to assess pathological inclusions and stage disease severity. Logistic regression analyses were used to identify pathological associations with clinical features. Results: All PD, PSP, and MSA cases had severe degeneration of the substantia nigra. Clinical features correlated with tissue loss and the severity of inclusion pathologies. Levodopa responsiveness and a lack of resting tremor was associated with preservation of pallidal volume, the presence of gait ataxia was associated with atrophy of the putamen, and the parkinsonian-plus phenotype with early falls and supranuclear vertical gaze abnormalities had more substantial midbrain atrophy and greater inclusion pathology in the caudate nucleus Discussion: This is the first study to compare the severity of regional pathologies across parkinsonian conditions. The data show that tissue loss and inclusion densities in certain regions correlate with clinical indices, with regional volume changes likely to be the best indicator of clinical progression of disease. (C) 2011 Movement Disorder Society
引用
收藏
页码:499 / 506
页数:8
相关论文
共 50 条
  • [31] Impaired skeletal muscle health in Parkinsonian syndromes: clinical implications, mechanisms and potential treatments
    Murphy, Kate T.
    Lynch, Gordon S.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2023, : 1987 - 2002
  • [32] Role of Apolipoprotein E in the Clinical Profile of Atypical Parkinsonian Syndromes
    Nasri, Amina
    Sghaier, Ikram
    Gharbi, Alya
    Mrabet, Saloua
    Ben Djebara, Mouna
    Gargouri, Amina
    Kacem, Imen
    Gouider, Riadh
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2022, 36 (01) : 36 - 43
  • [33] 99mTc-TRODAT-1 SPECT/CT imaging as a complementary biomarker in the diagnosis of parkinsonian syndromes
    Mittal, Bhagwant R.
    Sood, Apurva
    Shukla, Jaya
    Vatsa, Rakhee
    Bhusari, Priya
    Shree, Ritu
    Mehta, Sahil
    Goyal, Manoj
    Modi, Manish
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (04) : 312 - 318
  • [34] Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification
    Huppertz, Hans-Jurgen
    Moeller, Leona
    Suedmeyer, Martin
    Hilker, Ruediger
    Hattingen, Elke
    Egger, Karl
    Amtage, Florian
    Respondek, Gesine
    Stamelou, Maria
    Schnitzler, Alfons
    Pinkhardt, Elmar H.
    Oertel, Wolfgang H.
    Knake, Susanne
    Kassubek, Jan
    Hoeglinger, Guenter U.
    MOVEMENT DISORDERS, 2016, 31 (10) : 1506 - 1517
  • [35] Atypical parkinsonian syndromes
    Wenning, GK
    Pramstaller, PP
    Ransmayr, G
    Poewe, W
    NERVENARZT, 1997, 68 (02): : 102 - 115
  • [36] Hypodipsia Discriminates Progressive Supranuclear Palsy from Other Parkinsonian Syndromes
    Stamelou, Maria
    Christ, Helena
    Reuss, Alexander
    Oertel, Wolfgang
    Hoeglinger, Guenter
    MOVEMENT DISORDERS, 2011, 26 (05) : 901 - 905
  • [37] Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes
    Starhof, C.
    Winge, K.
    Heegaard, N. H. H.
    Skogstrand, K.
    Friis, S.
    Hejl, A.
    JOURNAL OF NEUROINFLAMMATION, 2018, 15
  • [38] Differentiation of atypical parkinsonian syndromes with routine MRI
    Schrag, A
    Good, CD
    Miszkiel, K
    Morris, HR
    Mathias, CJ
    Lees, AJ
    Quinn, NP
    NEUROLOGY, 2000, 54 (03) : 697 - 702
  • [39] Update on Therapeutic Strategies for Atypical Parkinsonian Syndromes
    Maghbooli, Mehdi
    Mohammadzadeh, Vida
    Yousefi, Mehran
    TURKISH JOURNAL OF NEUROLOGY, 2020, 26 (02) : 112 - 121
  • [40] Lower urinary tract dysfunction in Parkinsonian syndromes
    Vichayanrat, Ekawat
    Hentzen, Claire
    Batla, Amit
    Simeoni, Sara
    Iodice, Valeria
    Panicker, Jalesh N.
    NEUROLOGICAL SCIENCES, 2021, 42 (10) : 4045 - 4054